Jim Cramer Explains Mad Money Caller How to Handle Eton Pharmaceuticals (ETON)
During the lightning round of the August 26 Mad Money episode, a caller asked whether it is time to “cut it off” or if Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals Inc. (ETON)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Opaleye Management James A. Silverman | 2,860,000 | $103,532,000 | 9.38% | |
| 2. | EcoR1 Capital Oleg Nodelman | 2,171,938 | $78,624,156 | 3.82% | |
| 3. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 1,175,951 | $42,569,426 | 1.41% | |
| 4. | Woodline Partners Michael Rockefeller And Karl Kroeker | 310,879 | $11,253,820 | +83% | 0.03% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 249,182 | $9,020,387 | +202% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.82 | 2,930 | $46,364.03 | 85,000 | 2025-06-10 | Filing | |
| $15.82 | 5,000 | $79,119.50 | 2,770,000 | 2025-06-10 | Filing | |
| $7.98 | 10,000 | $79,814.00 | 2,770,000 | 2024-10-23 | Filing | |
| $7.03 | 3,970 | $27,905.92 | 82,070 | 2024-10-08 | Filing | |
| $7.03 | 30,000 | $210,876.00 | 2,760,000 | 2024-10-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $61.77 | 128 | $7,906.56 | 59,745 | 2026-08-28 | Filing | |
| $60.21 | 13,485 | $811,931.85 | 59,873 | 2026-08-28 | Filing | |
| $58.64 | 36,387 | $2,133,733.68 | 73,358 | 2026-08-28 | Filing | |
| $65.07 | 25,000 | $1,626,750.00 | 37,025 | 2026-08-24 | Filing | |
| $62.12 | 7,342 | $456,085.04 | 961,194 | 2026-08-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,895,833 | $68,629,156 | 0% | |
| 2. | 976,570 | $35,351,834 | 0% | |
| 3. | 767,972 | $27,800,585 | 0% | |
| 4. | 701,786 | $25,404,653 | 0% | |
| 5. | 652,303 | $23,618,970 | 0% |
News See All
Q2 Outliers: 16 Stocks Beating Earnings Estimates
Although technology and AI have remained central to the growth narrative in the second-quarter earnings season, the latest data shows that this season is not just a tech earnings story.
H.C. Wainwright Remains Bullish on Eton Pharmaceuticals' (ETON) Growth Strategy
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) is one of the best oversold growth stocks to invest in now. H.C. Wainwright lifted the price target on Eton Pharmaceuticals, Inc.
10 Oversold Growth Stocks to Invest In Now
On May 18, Jeffrey Solomon, vice chair and special advisor at TD Bank U.S., appeared on CNBC’s ‘Squawk on the Street’ to talk about how the Iran war and energy prices are driving markets, his economic...
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q1 2026 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Eton Pharmaceuticals First Quarter 2026 Financial Results Conference Call.
10 Best NASDAQ Growth Stocks to Buy and Hold Forever
On April 15, Kim Bolton, President & Portfolio Manager at Black Swan Dexteritas, appeared on BNN Bloomberg to share his outlook on Technology Stocks. Talking about how the Iran conflict over the last...
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2025 Earnings Call Transcript
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2025 Earnings Call Transcript March 19, 2026Eton Pharmaceuticals, Inc. misses on earnings expectations.
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q3 2025 Earnings Call Transcript
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q3 2025 Earnings Call Transcript November 6, 2025Eton Pharmaceuticals, Inc. misses on earnings expectations.
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q2 2025 Earnings Call Transcript
Operator: Thank you for standing by. My name is Alex, and I will be your conference operator for today.
Eton Pharmaceuticals, Inc. (ETON) Launches Game-Changer for Adrenal Insufficiency
Eton Pharmaceuticals, Inc.
Hedge Fund Resource Center